|Articles|October 1, 2015
- The Application Notebook-09-01-2015
- Issue 0
Chiral Separation of Beta Blocker Pindolol Enantiomers
Pindolol is a non-selective beta-blocker used for treatment of hypertension and angina pectoris. It is applied as a racemate, although only the (S)-form is the active stereoisomer.
YMC offers immobilized chiral phases that can be used either in normal or reversed phase mode as well as in supercritical fluid chromatography (SFC) mode. CHIRAL ART Cellulose-SC is a very versatile phase to separate many chiral substances. YMC have developed two isocratic applications to separate the pindolol enantiomers in normal phase or reversed phase mode. Both methods offer a high resolution. The normal phase application provides more potential for a preparative scale up, while the reversed phase approach separates the enantiomers in a shorter time.
Normal Phase Method
Column:
CHIRAL ART Cellulose-SC (250 × 4.6 mm, 5-μm)
Part No.:
KSC99S05-2546WT
Eluent:
n-hexane/ethanol/diethylamine (40/60/0.1)
Flow rate:
1.0 mL/min
Detection:
UV at 265 nm
Injection:
10 μL (100 μg/mL)
Temperature:
25 °C
Reversed Phase Method
Column:
CHIRAL ART Cellulose-SC (250 × 4.6 mm, 5-μm)
Part No.:
KSC99S05-2546WT
Eluent:
methanol/diethylamine (100/0.1)
Flow rate:
1.0 mL/min
Detection:
UV at 265 nm
Injection:
10 μL (100 μg/mL)
Temperature:
25 °C
YMC Europe GmbH
Phone: +49 2064 4270
E-mail:
Website:
Articles in this issue
about 10 years ago
GC–TEA Detection of Nitrosamines within Toys and Rubber/Latex Productsabout 10 years ago
Membrane Proteinsabout 10 years ago
UHPLC Analysis of Immunoglobulins with TSKgel® UP-SW3000 SEC Columnsabout 10 years ago
Blood Alcohol Content Analysis Using Nitrogen Carrier Gasover 10 years ago
Analysis of Organochlorine Pesticides (OCPs) on SGE BP5MSNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
